Search Results 271-280 of 17353 for meningococcal vaccine

  1. Combination Vaccine Immunotherapy (DRibbles) for Patients with Definitively-treated Stage III Non-small Cell Lung Cancer - Mayo Clinic

    This study will test an investigational vaccine, called DRibbles, for the treatment of non-small cell lung cancer (NSCLC). We hypothesize that vaccination with ...

  2. Gene Therapy for Muscular Dystrophy - Virology, Vector and Vaccine Engineering: Michael A. Barry - Mayo Clinic Research

    Learn about gene therapy for muscular dystrophy in the Virology, Vector and Vaccine Engineering Laboratory of Michael A. Barry, Ph.D., at Mayo Clinic.

  3. Mayo Clinic Minute: Vaccine being tested may help prevent breast cancer

    Each year, an estimated 268,000 new cases of invasive breast cancer will be diagnosed among U.S. women, according to the American Cancer Society.

  4. Personalized cancer vaccines: A new frontier in lung cancer treatment and prevention - Mayo Clinic

    "A cancer vaccine is similar to an infectious disease vaccine," says Dr. Knutson. "It's a medicine we give to stimulate the immune system with antigens ...

  5. Mayo Clinic Q and A: How different types of COVID-19 vaccines work

    If you become infected with the COVID-19 virus, these antibodies will fight the virus. After the messenger RNA vaccine helps your cells make the protein pieces, ...

  6. Faculty and staff - Vaccines: Gregory A. Poland, Richard B. Kennedy - Mayo Clinic Research

    View faculty and staff of Mayo Clinic's Vaccine Research Group led by Gregory A. Poland, M.D.; Richard B. Kennedy, Ph.D.; and Inna G. Ovsyannikova, Ph.D.

  7. Mayo Clinic preparing for COVID-19 vaccine boosters when approved

    The workgroup is closely monitoring booster vaccine development and recommendations and creating a process to administer booster vaccines once they are approved ...

  8. Sustained Humoral and Cell-Mediated Immunogenicity of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease - Mayo Clinic

    ... vaccination. The primary outcome of this study is to evaluate the immunogenicity of the Covid-19 vaccine in patients with IBD. Participation eligibility.

  9. COVID-19 vaccine update - Mayo Clinic News Network

    Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, gives an update on vaccine approval and discusses logistics ...

  10. ... vaccine live(PF)1,000-12,500TCID50/0.5 mL subcut",121.9 125,636000003,49281086010,poliovirus vaccine 40 unit-8 unit-32 unit/0.5 mL injection suspension,35.4 ...